nicardipine has been researched along with atenolol in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (31.03) | 18.7374 |
| 1990's | 10 (34.48) | 18.2507 |
| 2000's | 6 (20.69) | 29.6817 |
| 2010's | 4 (13.79) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Bruno-Blanch, L; Gálvez, J; García-Domenech, R | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Andriani, A; De Cesaris, R; Filitti, V; Ranieri, G | 1 |
| Cataldo, R; Guerrera, C; Guerrera, G; Melina, D; Musumeci, V; Nicolò, G; Santoliquido, A | 1 |
| Arosio, E; Lechi, A; Pancera, P; Priante, F; Ribul, M; Talamini, G; Zannoni, M | 1 |
| Berdeaux, A; Drieu la Rochelle, C; Giudicelli, JF; Richard, V | 1 |
| Thomas, SH | 1 |
| Dupont, AG; Massart, DL; Musch, G; Schoors, DF; Vercruysse, I | 1 |
| Chikvashvili, IA; Kamenker, ES; Zadionchenko, VS | 1 |
| Broustet, JP; Douard, H; Mora, B | 1 |
| Silke, B; Taylor, SH; Verma, SP; Zezulka, AV | 1 |
| Goto, K; Ishikawa, T; Kimura, S; Masaki, T; Yanagisawa, M | 1 |
| Custro, N; Scafidi, V | 1 |
| Coxhead, PF; Douglas-Jones, AP | 1 |
| Kolloch, R; Overlack, A; Stumpe, KO | 1 |
| Woodson, LC; Ziegler, MG | 1 |
| Freslon, JL; Giudicelli, JF; Richer, C | 1 |
| Hagihara, T; Kishi, Y; Matsumoto, G; Matsuo, H; Naka, K; Nanjo, K; Ohoshi, T; Sanke, T; Sasaki, H; Sowa, R | 1 |
| Bretnall, AE; Clarke, GS | 1 |
| Fox, KM; Keegan, J; Mulcahy, D; Parameshwar, J; Phadke, K; Sparrow, J; Sutton, GC | 1 |
| Ichikawa, M; Jimbo, M; Kumagai, K; Nishizawa, M; Ryuzaki, M; Saruta, T; Suzuki, H | 1 |
1 review(s) available for nicardipine and atenolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 trial(s) available for nicardipine and atenolol
| Article | Year |
|---|---|
Large artery compliance in essential hypertension. Effects of calcium antagonism and beta-blocking.
Topics: Adrenergic beta-Antagonists; Adult; Arteries; Atenolol; Blood Pressure; Calcium Channel Blockers; Compliance; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nicardipine; Time Factors; Vascular Resistance | 1992 |
Comparison of the cardiovascular effects of nifedipine and nicardipine in the presence of atenolol.
Topics: Administration, Oral; Adult; Atenolol; Blood Pressure; Double-Blind Method; Drug Interactions; Exercise Test; Heart Rate; Hemodynamics; Humans; Male; Nicardipine; Nifedipine; Stroke Volume | 1991 |
Nicardipine does not influence the pharmacokinetics and pharmacodynamics of atenolol.
Topics: Adult; Atenolol; Drug Interactions; Female; Humans; Male; Nicardipine | 1990 |
Comparison of the anti-anginal efficacy of nicardipine and nifedipine in patients receiving atenolol: a randomized, double-blind, crossover study.
Topics: Angina Pectoris; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Synergism; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Nicardipine; Nifedipine; Random Allocation | 1989 |
Hemodynamic assessment of nicardipine alone and with atenolol in coronary artery disease using a modified echo-Doppler device.
Topics: Adult; Aged; Atenolol; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echocardiography, Doppler; Hemodynamics; Humans; Middle Aged; Nicardipine; Random Allocation | 1989 |
[Effects of chronic administration of several calcium antagonists on pituitary release of TSH].
Topics: Adult; Atenolol; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease; Humans; Hypertension; Male; Middle Aged; Nicardipine; Nifedipine; Pituitary Gland, Anterior; Random Allocation; Thyrotropin; Time Factors; Verapamil | 1987 |
A general practice trial of antihypertensive therapy comparing a combination of nicardipine and chlorthalidone with atenolol and chlorthalidone.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Chlorthalidone; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Middle Aged; Nicardipine; Nifedipine | 1986 |
Blood pressure, heart rate and A-V conduction responses to nicardipine in hypertensive patients receiving atenolol.
Topics: Adult; Atenolol; Blood Pressure; Calcium Channel Blockers; Drug Therapy, Combination; Female; Heart Conduction System; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nicardipine; Nifedipine | 1985 |
Atenolol or nicardipine alone is as efficacious in stable angina as their combination: a double blind randomised trial.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Double-Blind Method; Drug Therapy, Combination; Exercise; Female; Gated Blood-Pool Imaging; Humans; Male; Middle Aged; Nicardipine | 1993 |
19 other study(ies) available for nicardipine and atenolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship | 2003 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Efficacy of the combination of nicardipine-enalapril and atenolol in severe hypertension secondary to chronic renal disease].
Topics: Adult; Atenolol; Chronic Disease; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension, Renal; Kidney Diseases; Male; Middle Aged; Nicardipine; Treatment Outcome | 1992 |
Changes in the haemodynamics of large arteries induced by single doses of nicardipine, enalapril, atenolol and urapidil.
Topics: Adult; Antihypertensive Agents; Atenolol; Blood Pressure; Brachial Artery; Carotid Arteries; Enalapril; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nicardipine; Piperazines; Vascular Resistance | 1992 |
Coronary effects of a combined beta adrenoceptor blocking and calcium antagonist therapy in running dogs.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Calcium Channel Blockers; Coronary Vessels; Dihydropyridines; Dogs; Hemodynamics; Nicardipine; Nitrophenols; Running | 1991 |
[Changes in the platelet-vascular system of hemostasis in patients with ischemic heart disease and hypertension after the treatment].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Coagulation; Calcium Channel Blockers; Coronary Disease; Coronary Vessels; Female; Humans; Hypertension; Male; Middle Aged; Nicardipine; Platelet Aggregation | 1989 |
Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea pig atria.
Topics: Action Potentials; Adrenergic alpha-Antagonists; Animals; Atenolol; Atrial Function; Calcium; Cimetidine; Diphenhydramine; Endothelins; Guinea Pigs; Heart Atria; In Vitro Techniques; Isoproterenol; Male; Methysergide; Myocardial Contraction; Nicardipine; Peptides; Potassium; Quinazolines; Reference Values | 1988 |
Pressor response to beta-blocking drugs.
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Female; Humans; Hypertension; Isoproterenol; Middle Aged; Nicardipine; Nifedipine; Norepinephrine; Pressoreceptors | 1984 |
[Antihypertensives and the prevention of development of genetic hypertension in the hypertensive SHR rat].
Topics: Animals; Antihypertensive Agents; Atenolol; Captopril; Cardiomegaly; Dihydralazine; Dose-Response Relationship, Drug; Hydrochlorothiazide; Hypertension; Male; Nicardipine; Nifedipine; Prazosin; Rats; Rats, Inbred Strains; Time Factors; Vasodilator Agents | 1980 |
Nicardipine may impair glucose metabolism in hypertensive diabetic patients.
Topics: Adult; Aged; Atenolol; Carteolol; Diabetes Mellitus, Type 2; Diltiazem; Enalapril; Female; Glucose; Glycated Hemoglobin; Humans; Hypertension; Male; Metoprolol; Middle Aged; Nicardipine; Propanolamines | 1994 |
Investigation and optimisation of the use of micellar electrokinetic chromatography for the analysis of six cardiovascular drugs.
Topics: Amlodipine; Atenolol; Cardiovascular Agents; Chromatography; Diltiazem; Electrochemistry; Hydrogen-Ion Concentration; Kinetics; Micelles; Nicardipine; Nifedipine; Osmosis; Sodium Dodecyl Sulfate; Verapamil | 1995 |
Comparison of early and late start of antihypertensive agents and baroreceptor reflexes.
Topics: Aging; Animals; Antihypertensive Agents; Atenolol; Baroreflex; Blood Pressure; Enalapril; Heart Rate; Hypertension; Kidney; Male; Nicardipine; Pressoreceptors; Rats; Rats, Inbred SHR; Sympathetic Nervous System; Tachycardia; Trichlormethiazide | 1996 |